R&D How lab automation reinforces regulatory compliance for bioa... Automation holds the potential to enhance scientific rigour and operational efficiency while solving long-standing regulatory conundrums.
R&D Unlocking the future of neurodegeneration research: How auto... On the emergence of brain organoids and the advent of automation, the latter being essential for high-throughput approaches drug development demands.
Digital We can’t fix modern healthcare with 1950s solutions. AI is t... In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.
Digital Understanding how technology fits into the evolving role of ... As technology reshapes healthcare, pharmacists are leveraging automation, telehealth, and digital tools to transform how care is delivered
R&D When costing and compliance collide Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost.
News Scientific 'superintelligence' firm Lila launches with $200m Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.